Activity value 81india Buyer&Supplier,Last transaction date:
2026-02-19Address: 7/1 corporate park sion trombay roamumbai mh 400072 india
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for flamingo pharmaceuticals from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 43 transactions, with a transaction quantity of 3266.15 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025220292369.250
2026433266.150
Bill of lading data
<
1/15
>
Trade date
2026/02/19
B/L No.
8587027
Suppliers
hangzhou taywell international trade co ltd
Buyers
flamingo pharmaceuticals
Product description
BISOPROLOL FOR SYSTEM SUITABILITY CRS1 003 MG PER VIAL FORLABORATORY USE ONLY NOT FOR HUMAN & ANIMAL CONSUMPTION BISOPROLOL FOR SYSTEM SUITABILITY CRS
Expand
Trade date
2026/01/23
B/L No.
1505636
Suppliers
conseil de l europe edqm c
Buyers
flamingo pharmaceuticals
Product description
SODIUM CROMOGLICATE FOR SYSTEM SUITABILITY CRS20MG PER VIAL FOR LABORATORY USE ONLY NOT FOR HUMAN & ANIMAL CONSUMPTIONSODIUM CROMOGLICATE FOR SYSTEM SUITABILITY CRS
Expand
Trade date
2026/01/23
B/L No.
5577202
Suppliers
conseil de l europe edqm c
Buyers
flamingo pharmaceuticals
Product description
OMEPRAZOLE FOR PEAK IDENTIFICATION CRS10 MG PER VIAL FOR LABORATORY USE ONLY NOT FOR HUMAN & ANIMAL CONSUMPTION OMEPRAZOLE FOR PEAK IDENTIFICATION CRS
Expand
Trade date
2026/01/23
B/L No.
8618316
Suppliers
conseil de l europe edqm c
Buyers
flamingo pharmaceuticals
Product description
QUETIAPINE FOR SYSTEM SUITABILITY CRS 2 MG PER VIAL FOR LABORATORY USE ONLY NOT FOR HUMAN & ANIMAL CONSUMPTION QUETIAPINE FOR SYSTEM SUITABILITY CRS
Expand
flamingo pharmaceuticals is india Buyer&Supplier,
and primarily engages in the import and export business of products such as human,laboratory,nima.
According to the 52wmb.com global trade database, as of 2026-02-19, the company has completed 20873 international trades,
with its main trading regions covering china,france,england etc.
The core products include HS29419090,HS29339990,HS29349990 etc,
often transported via sahar air cargo acc inbom4,port nhava sheva, port nhava sheva sea innsa1 etc,
and its main trading partners are conseil de l europe edqm c,british pharmacopea commission,china sinopharminter shanghai.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on flamingo pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.